CHARACTERIZATION OF SUB-EPITHELIAL ANTIGENS
上皮下抗原的表征
基本信息
- 批准号:3157347
- 负责人:
- 金额:$ 13.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-09-23 至 1993-08-31
- 项目状态:已结题
- 来源:
- 关键词:affinity chromatography antibody basement membrane collagen complementary DNA electron microscopy epidermolysis bullosa epithelium extracellular matrix gel electrophoresis heterozygote histochemistry /cytochemistry human tissue immunochemistry intercellular connection keratin keratinocyte laboratory mouse laboratory rabbit laminin monoclonal antibody protein sequence skin surface antigens tissue /cell culture
项目摘要
Human skin keratinocytes are affixed to the underlying dermal
matrix by a complex attachment mechanism, many elements of
which are unique to external eipthelia. These include the
hemidesmosomes which mediate attachment of keratin filaments
to the basolateral plasma membrane, anchoring filaments that
appear to bridge the hemidesmosomes to the lamina densa of the
basement membrane, and the anchoring fibril network, that
attaches the lamina densa to the subjacent dermis by physical
entrapment of dermal fibrous elements. Failure of this
attachment complex results in several forms of the blistering
diseases jointly termed Epidermolysis Bullosa (EB). While the
phenomena of dermal-epidermal separation is well documented,
the molecular events leading of these separations are not
unambiguously known. During the past three years of funding,
this grant has supported studies that identified a large and
complex C-terminal globular domain of type VII collagen (NC-1)
and indicated involvement of this domain in a new model of the
anchoring fibril network. The model is based upon structural
characterization of type VII collagen and ultrastructural
immunolocalization of NC-1. The model predicts interactions of
NC-1 with itself, with type IV collagen and with other intrinsic
basement membrane components both with the lamina densa and
within structures we have termed "anchoring plaques".
This application proposes continuation of these studies to: (1)
investigate the possible interactions of NC-1 with itself and with
domains of type IV collagen and other basement membrane
proteins using solid phase interaction assays and biophysical
techniques; (2) to attempt to isolate additional NC-1 binding
proteins by affinity chromatography and to characterize their
structures; (3) to begin identification of the structural
components of hemidesmosomes by first producing monoclonal
antibodies to membrane fractions enriched for them and use of
these antibodies for immunoisolation and structural
characterization of them; and (4) to assess the ability of cultured
EB keratinocytes to synthesize type VII collagen using cDNA
hybridization and immunoblotting techniques, and to evaluate the
defective anchoring fibril networks of individuals with recessive
dystrophic EB relative to the above described model, using
electron microscope immunohistochemistry.
人的皮肤角质形成细胞附着在下面的真皮上
矩阵通过复杂的附着机制,许多元素
这是外部针叶植物所独有的。其中包括
介导角蛋白细丝附着的半桥粒
到基侧质膜,锚定细丝,
似乎将半桥粒连接到大脑的致密层
基底膜和锚定纤维网络,
通过物理方法将致密层附着在真皮下
夹住真皮纤维成分。这是失败的
附着复合体导致几种形式的水泡
统称为大疱性表皮松解症(EB)。而当
真皮-表皮分离的现象被很好地记录下来,
导致这些分离的分子事件并不是
毫不含糊地知道。在过去三年的资助中,
这笔赠款支持了一些研究,这些研究确定了一个大型和
III型胶原复合体C末端球状结构域(NC-1)
并指出这个领域参与了一种新的
锚定原纤网。该模型基于结构
III型胶原蛋白的特性及超微结构
NC-1的免疫定位。该模型预测了
NC-1与自身、IV型胶原和其他固有的
基底膜成分包括致密层和
在结构内,我们将其称为“锚定斑块”。
本申请建议继续进行这些研究:(1)
研究NC-1与其自身以及与其之间可能的相互作用
IV型胶原和其他基底膜的结构域
蛋白质固相相互作用分析和生物物理研究
技术;(2)尝试分离额外的NC-1结合
蛋白质的亲和层析,并对它们的特性进行分析
结构;(3)开始识别结构
首次制备单抗制备半桥粒组分的研究
对它们富含的膜部分的抗体和使用
这些抗体用于免疫分离和结构
它们的特性;以及(4)评估培养的能力
EB角质形成细胞利用c DNA合成VII型胶原
杂交和免疫印迹技术,并评估
隐性遗传病个体的锚定纤维网络缺陷
营养不良EB相对于上述模型,使用
电子显微镜免疫组织化学。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT E BURGESON其他文献
ROBERT E BURGESON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT E BURGESON', 18)}}的其他基金
STRUCTURE AND FUNCTION OF NON BASEMENT MEMBRANE LAMININS
非基底膜层粘连蛋白的结构和功能
- 批准号:
6351902 - 财政年份:2000
- 资助金额:
$ 13.72万 - 项目类别:
STRUCTURE AND FUNCTION OF NON BASEMENT MEMBRANE LAMININS
非基底膜层粘连蛋白的结构和功能
- 批准号:
6033691 - 财政年份:2000
- 资助金额:
$ 13.72万 - 项目类别:
CHARACTERIZATION OF SUB-EPITHELIAL MATRIX ANTIGENS
上皮下基质抗原的表征
- 批准号:
3157342 - 财政年份:1985
- 资助金额:
$ 13.72万 - 项目类别:
CHARACTERIZATION OF SUB-EPITHELIAL MATRIX ANTIGENS
上皮下基质抗原的表征
- 批准号:
3157343 - 财政年份:1985
- 资助金额:
$ 13.72万 - 项目类别:
相似海外基金
Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
- 批准号:
502607 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
- 批准号:
EP/Y024540/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Fellowship
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
- 批准号:
MR/Y008847/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
- 批准号:
BB/Y002180/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Research Grant
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
- 批准号:
MR/Y003616/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
- 批准号:
MR/Y033698/1 - 财政年份:2024
- 资助金额:
$ 13.72万 - 项目类别:
Research Grant
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
- 批准号:
23H03716 - 财政年份:2023
- 资助金额:
$ 13.72万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis research of anti-Sez6l2 antibody associated encephalopathy
抗Sez6l2抗体相关脑病的分析研究
- 批准号:
23K06940 - 财政年份:2023
- 资助金额:
$ 13.72万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




